Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab

New England Journal of Medicine

Volumn 344, Issue 1, 2001, Pages 68-69

  Dervite, Isabelle ^a   Hober, Didier ^b   Morel, Pierre ^a  

^a Centre Hospitalier de LENS   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; AMINOTRANSFERASE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; HEPATITIS B SURFACE ANTIGEN; PREDNISONE; RITUXIMAB;

ACUTE HEPATITIS; AGED; ANTIBODY DETECTION; CASE REPORT; DRUG SAFETY; HEPATITIS B; HUMAN; JAUNDICE; LETTER; LIVER FUNCTION TEST; LYMPHOMA; MALE; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 0035804282     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200101043440120     Document Type: Letter

References (5)

1. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
2. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy: Report of a prospective study
3. Acute hepatitis B after autologous stem cell transplantation in a man previously infected by hepatitis B virus
4. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: Report on three cases and review of the literature
5. Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal